7.100
−2,74%
2026-10-19
Fundamental Analysis
74 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +97.7% | +684.2% | 2 / 3 | +109.0% | +0.48 pp | -0.02 pp | +13.0% | 0.01 | 3.54 | 2.284 | +109,0% | 9,2 | +97,7% | 3.54 | 7.60 | −53,5% |
| Pts | 12 | 12 | 8 | 12 | 8 | 4 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 7.100 (close price on 2026-10-19)EPS (TTM): 2.007
Financial charts
1.Revenue & growth
VND bn2.284Q2/26
1.Revenue & growth
VND bn2.284Q2/26
2.Profit & growth
VND bn9,23Q2/26
3.Profit mix (Penman)
VND bn33,2Q2/26
4.Margins & cost structure
%3.8%Q2/26
5.Returns & cash cycle
% · days11.7%Q2/26
6.Earnings quality & cash
VND bn22,8Q2/26
7.Asset structure
VND bn506Q2/26
8.Funding & debt health
VND bn · times506Q2/26
9.Revenue backlog
VND bn4,96Q2/26
10.Valuation
times · %3,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %738Q2/26
Adjusted EPS growth, latest quarter
97.7%
Average adjusted EPS growth, 3 quarters
25.6%
averaged over 2 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26